Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Drugs in tuberculosis and leprosy
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Drugs in tuberculosis and leprosy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
50%
Aminoglycoside
50%
Aminosalicylic Acid
50%
Bedaquiline
50%
Carbapenem Derivative
50%
Clofazimine
50%
Cycloserine
50%
Dapsone
50%
Ethambutol
50%
Isoniazid
50%
Latent Tuberculosis
50%
Linezolid
50%
Macrolide
50%
Polypeptide
50%
Pyrazinamide
50%
Quinolone Derivative
50%
Rifamycin
50%
Terizidone
50%
Thioacetazone
50%
Tuberculosis
100%
Keyphrases
5-aminosalicylic Acid (5-ASA)
25%
Active Tuberculosis
25%
Adverse Effects
25%
Aminoglycosides
25%
Bedaquiline
25%
Carbapenems
25%
Clofazimine
25%
D-cycloserine
25%
Dapsone
25%
Drug Interactions
25%
Ethambutol
25%
Fluoroquinolones
25%
Global Health Issue
25%
Interaction Outcome
25%
Latent Tuberculosis Infection
25%
Leprosy
100%
Linezolid
25%
Macrolides
25%
Medication Effects
25%
Patient's Will
25%
Polypeptide
25%
Pyrazinamide
25%
Resistance Pattern
25%
Rifamycin
25%
Terizidone
25%
Thiacetazone
25%
Toxicity Profile
25%
Treatment Outcome
25%
Treatment Regimen
25%
Tuberculosis
100%
World Population
25%